Pharmacist intervention in outpatients with hypertension, type 2 diabetes mellitus, ad impact on cardiovascular risk
Department of Pharmacology, Jaipur college of Pharmacy, Jaipur, Rajasthan, India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2023, 16(02), 149–155
Article DOI: 10.30574/wjbphs.2023.16.2.0436
Publication history:
Received on 03 September 2023; revised on 15 October 2023; accepted on 18 October 2023
Abstract:
About 80% of CVDs are linked to behavioral risk factors. The effects of physical inactivity and unhealthy diet may present in an individual as overweight and obesity, high blood pressure, elevated blood glucose levels, and elevated blood lipid levels. Aim: This study aims to assess the impact of pharmacist interventions focusing on the medical risk factors for primary prevention in outpatients with Hypertension, Diabetes and their impact on Cardiovascular risk. Material and Methods: The selected patients were grouped randomly into interventional and usual care groups. The different intervention steps and the protocol of the study were explained to the patients included in the interventional group whereas the normal care group will be directed to follow their normal treatment protocol. Results & Conclusion: In both interventional group (61.3%) and usual care group (57.7%) majority were females. The age group of the patients varied from 41 to 70. There were significantly results in the Interventional group in clinical outcomes, biomedical outcomes and adherence of medication compared with the Usual care group.
Keywords:
Pharmacist Intervention; Cardiovascular risk; Adherence; Hypertension
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0